# Open-Label Extension Study of Kuvan for Autism

> **NCT00943579** · PHASE2,PHASE3 · COMPLETED · sponsor: **The Children's Health Council** · enrollment: 41 (actual)

## Conditions studied

- Autistic Disorder

## Interventions

- **DRUG:** Kuvan®

## Key facts

- **NCT ID:** NCT00943579
- **Lead sponsor:** The Children's Health Council
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-12
- **Final completion:** 2012-03
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2018-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00943579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00943579, "Open-Label Extension Study of Kuvan for Autism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00943579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*